nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—Dacarbazine—pancreatic cancer	0.211	0.261	CbGbCtD
Clobetasol propionate—CYP1A1—Tamoxifen—pancreatic cancer	0.168	0.207	CbGbCtD
Clobetasol propionate—CYP1A1—Erlotinib—pancreatic cancer	0.143	0.176	CbGbCtD
Clobetasol propionate—CYP1A2—Dacarbazine—pancreatic cancer	0.0943	0.116	CbGbCtD
Clobetasol propionate—CYP1A2—Tamoxifen—pancreatic cancer	0.075	0.0926	CbGbCtD
Clobetasol propionate—CYP1A2—Erlotinib—pancreatic cancer	0.0638	0.0787	CbGbCtD
Clobetasol propionate—CYP1A2—Fluorouracil—pancreatic cancer	0.0553	0.0682	CbGbCtD
Clobetasol propionate—Pustule—Erlotinib—pancreatic cancer	0.0159	0.0836	CcSEcCtD
Clobetasol propionate—Rosacea—Erlotinib—pancreatic cancer	0.00986	0.0518	CcSEcCtD
Clobetasol propionate—Application site burn—Fluorouracil—pancreatic cancer	0.00701	0.0369	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.0063	0.0331	CcSEcCtD
Clobetasol propionate—Telangiectasia—Fluorouracil—pancreatic cancer	0.00624	0.0328	CcSEcCtD
Clobetasol propionate—Leukoderma—Sunitinib—pancreatic cancer	0.00438	0.023	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Fluorouracil—pancreatic cancer	0.00421	0.0221	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.00362	0.019	CcSEcCtD
Clobetasol propionate—Folliculitis—Erlotinib—pancreatic cancer	0.00342	0.018	CcSEcCtD
Clobetasol propionate—Application site pain—Fluorouracil—pancreatic cancer	0.00334	0.0176	CcSEcCtD
Clobetasol propionate—Application site reaction—Fluorouracil—pancreatic cancer	0.00313	0.0165	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.00313	0.0165	CcSEcCtD
Clobetasol propionate—Rash pustular—Erlotinib—pancreatic cancer	0.0027	0.0142	CcSEcCtD
Clobetasol propionate—Tenderness—Tamoxifen—pancreatic cancer	0.00249	0.0131	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.00247	0.013	CcSEcCtD
Clobetasol propionate—Tenderness—Erlotinib—pancreatic cancer	0.00247	0.013	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—pancreatic cancer	0.00243	0.0128	CcSEcCtD
Clobetasol propionate—Eruption—Gemcitabine—pancreatic cancer	0.00243	0.0128	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—pancreatic cancer	0.00225	0.0118	CcSEcCtD
Clobetasol propionate—Tingling sensation—Fluorouracil—pancreatic cancer	0.00183	0.00961	CcSEcCtD
Clobetasol propionate—Stinging—Fluorouracil—pancreatic cancer	0.00181	0.00954	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.00178	0.00938	CcSEcCtD
Clobetasol propionate—Eruption—Docetaxel—pancreatic cancer	0.00172	0.00907	CcSEcCtD
Clobetasol propionate—Eye irritation—Fluorouracil—pancreatic cancer	0.00172	0.00905	CcSEcCtD
Clobetasol propionate—Tenderness—Gemcitabine—pancreatic cancer	0.00171	0.00901	CcSEcCtD
Clobetasol propionate—Tenderness—Fluorouracil—pancreatic cancer	0.00168	0.00886	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—pancreatic cancer	0.00168	0.00885	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—pancreatic cancer	0.00156	0.00819	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Fluorouracil—pancreatic cancer	0.00145	0.00764	CcSEcCtD
Clobetasol propionate—Dry skin—Erlotinib—pancreatic cancer	0.00143	0.00753	CcSEcCtD
Clobetasol propionate—Pain in extremity—Sunitinib—pancreatic cancer	0.00135	0.00711	CcSEcCtD
Clobetasol propionate—Eye irritation—Docetaxel—pancreatic cancer	0.00124	0.00653	CcSEcCtD
Clobetasol propionate—Dry skin—Sunitinib—pancreatic cancer	0.00124	0.00652	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.0012	0.00632	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—pancreatic cancer	0.00116	0.00612	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—pancreatic cancer	0.00114	0.00599	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—pancreatic cancer	0.00114	0.00599	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.00111	0.00585	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00109	0.00571	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—pancreatic cancer	0.00108	0.00566	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00108	0.00566	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Erlotinib—pancreatic cancer	0.00106	0.00558	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00105	0.00554	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—pancreatic cancer	0.00105	0.00554	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—pancreatic cancer	0.00105	0.00554	CcSEcCtD
Clobetasol propionate—Dry skin—Fluorouracil—pancreatic cancer	0.000978	0.00514	CcSEcCtD
Clobetasol propionate—Alopecia—Tamoxifen—pancreatic cancer	0.000965	0.00507	CcSEcCtD
Clobetasol propionate—Alopecia—Erlotinib—pancreatic cancer	0.000955	0.00502	CcSEcCtD
Clobetasol propionate—Erythema—Tamoxifen—pancreatic cancer	0.000951	0.005	CcSEcCtD
Clobetasol propionate—Erythema—Erlotinib—pancreatic cancer	0.000941	0.00495	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Sunitinib—pancreatic cancer	0.000931	0.00489	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Sunitinib—pancreatic cancer	0.000921	0.00485	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000919	0.00483	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—pancreatic cancer	0.000897	0.00472	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—pancreatic cancer	0.000883	0.00464	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—pancreatic cancer	0.000883	0.00464	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000846	0.00445	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—pancreatic cancer	0.00083	0.00436	CcSEcCtD
Clobetasol propionate—Alopecia—Sunitinib—pancreatic cancer	0.000827	0.00435	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—pancreatic cancer	0.000817	0.0043	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—pancreatic cancer	0.000817	0.0043	CcSEcCtD
Clobetasol propionate—Erythema—Sunitinib—pancreatic cancer	0.000814	0.00428	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000795	0.00418	CcSEcCtD
Clobetasol propionate—Infection—Tamoxifen—pancreatic cancer	0.000771	0.00405	CcSEcCtD
Clobetasol propionate—Pain in extremity—Docetaxel—pancreatic cancer	0.00077	0.00405	CcSEcCtD
Clobetasol propionate—Infection—Erlotinib—pancreatic cancer	0.000763	0.00401	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000757	0.00398	CcSEcCtD
Clobetasol propionate—Skin disorder—Erlotinib—pancreatic cancer	0.000746	0.00392	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000739	0.00389	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000738	0.00388	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000734	0.00386	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Epirubicin—pancreatic cancer	0.000707	0.00372	CcSEcCtD
Clobetasol propionate—Dry skin—Docetaxel—pancreatic cancer	0.000706	0.00371	CcSEcCtD
Clobetasol propionate—Paraesthesia—Tamoxifen—pancreatic cancer	0.000697	0.00366	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000688	0.00362	CcSEcCtD
Clobetasol propionate—Alopecia—Irinotecan—pancreatic cancer	0.000681	0.00358	CcSEcCtD
Clobetasol propionate—Pain—Tamoxifen—pancreatic cancer	0.000664	0.00349	CcSEcCtD
Clobetasol propionate—Alopecia—Gemcitabine—pancreatic cancer	0.000663	0.00349	CcSEcCtD
Clobetasol propionate—Infection—Sunitinib—pancreatic cancer	0.00066	0.00347	CcSEcCtD
Clobetasol propionate—Pain—Erlotinib—pancreatic cancer	0.000656	0.00345	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000654	0.00344	CcSEcCtD
Clobetasol propionate—Erythema—Gemcitabine—pancreatic cancer	0.000653	0.00344	CcSEcCtD
Clobetasol propionate—Alopecia—Fluorouracil—pancreatic cancer	0.000652	0.00343	CcSEcCtD
Clobetasol propionate—Skin disorder—Sunitinib—pancreatic cancer	0.000646	0.00339	CcSEcCtD
Clobetasol propionate—Erythema—Fluorouracil—pancreatic cancer	0.000642	0.00338	CcSEcCtD
Clobetasol propionate—Paraesthesia—Sunitinib—pancreatic cancer	0.000597	0.00314	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—pancreatic cancer	0.000581	0.00305	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000572	0.00301	CcSEcCtD
Clobetasol propionate—Pain—Sunitinib—pancreatic cancer	0.000568	0.00299	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000552	0.0029	CcSEcCtD
Clobetasol propionate—Pruritus—Tamoxifen—pancreatic cancer	0.000549	0.00289	CcSEcCtD
Clobetasol propionate—Infection—Irinotecan—pancreatic cancer	0.000544	0.00286	CcSEcCtD
Clobetasol propionate—Pruritus—Erlotinib—pancreatic cancer	0.000543	0.00286	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—pancreatic cancer	0.000539	0.00283	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—pancreatic cancer	0.000537	0.00282	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00053	0.00279	CcSEcCtD
Clobetasol propionate—Infection—Gemcitabine—pancreatic cancer	0.00053	0.00279	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Docetaxel—pancreatic cancer	0.000525	0.00276	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000523	0.00275	CcSEcCtD
Clobetasol propionate—Infection—Fluorouracil—pancreatic cancer	0.000521	0.00274	CcSEcCtD
Clobetasol propionate—Pain in extremity—Epirubicin—pancreatic cancer	0.000519	0.00273	CcSEcCtD
Clobetasol propionate—Skin disorder—Gemcitabine—pancreatic cancer	0.000518	0.00272	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—pancreatic cancer	0.000499	0.00262	CcSEcCtD
Clobetasol propionate—Paraesthesia—Irinotecan—pancreatic cancer	0.000492	0.00258	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Sunitinib—pancreatic cancer	0.00049	0.00257	CcSEcCtD
Clobetasol propionate—Rash—Tamoxifen—pancreatic cancer	0.000489	0.00257	CcSEcCtD
Clobetasol propionate—Dermatitis—Tamoxifen—pancreatic cancer	0.000489	0.00257	CcSEcCtD
Clobetasol propionate—Headache—Tamoxifen—pancreatic cancer	0.000486	0.00256	CcSEcCtD
Clobetasol propionate—Rash—Erlotinib—pancreatic cancer	0.000484	0.00255	CcSEcCtD
Clobetasol propionate—Dermatitis—Erlotinib—pancreatic cancer	0.000484	0.00254	CcSEcCtD
Clobetasol propionate—Headache—Erlotinib—pancreatic cancer	0.000481	0.00253	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—pancreatic cancer	0.000481	0.00253	CcSEcCtD
Clobetasol propionate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000479	0.00252	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—pancreatic cancer	0.000476	0.0025	CcSEcCtD
Clobetasol propionate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000471	0.00248	CcSEcCtD
Clobetasol propionate—Alopecia—Docetaxel—pancreatic cancer	0.000471	0.00248	CcSEcCtD
Clobetasol propionate—Pruritus—Sunitinib—pancreatic cancer	0.00047	0.00247	CcSEcCtD
Clobetasol propionate—Pain—Irinotecan—pancreatic cancer	0.000468	0.00246	CcSEcCtD
Clobetasol propionate—Erythema—Docetaxel—pancreatic cancer	0.000464	0.00244	CcSEcCtD
Clobetasol propionate—Pain—Gemcitabine—pancreatic cancer	0.000456	0.0024	CcSEcCtD
Clobetasol propionate—Pain—Fluorouracil—pancreatic cancer	0.000448	0.00236	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—pancreatic cancer	0.00044	0.00232	CcSEcCtD
Clobetasol propionate—Rash—Sunitinib—pancreatic cancer	0.000419	0.0022	CcSEcCtD
Clobetasol propionate—Dermatitis—Sunitinib—pancreatic cancer	0.000419	0.0022	CcSEcCtD
Clobetasol propionate—Headache—Sunitinib—pancreatic cancer	0.000416	0.00219	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000405	0.00213	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000403	0.00212	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000392	0.00206	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000386	0.00203	CcSEcCtD
Clobetasol propionate—Pruritus—Gemcitabine—pancreatic cancer	0.000377	0.00198	CcSEcCtD
Clobetasol propionate—Infection—Docetaxel—pancreatic cancer	0.000376	0.00198	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000375	0.00197	CcSEcCtD
Clobetasol propionate—Pruritus—Fluorouracil—pancreatic cancer	0.000371	0.00195	CcSEcCtD
Clobetasol propionate—Skin disorder—Docetaxel—pancreatic cancer	0.000368	0.00193	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000357	0.00188	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Epirubicin—pancreatic cancer	0.000354	0.00186	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000353	0.00186	CcSEcCtD
Clobetasol propionate—Rash—Irinotecan—pancreatic cancer	0.000345	0.00182	CcSEcCtD
Clobetasol propionate—Dermatitis—Irinotecan—pancreatic cancer	0.000345	0.00181	CcSEcCtD
Clobetasol propionate—Headache—Irinotecan—pancreatic cancer	0.000343	0.0018	CcSEcCtD
Clobetasol propionate—Paraesthesia—Docetaxel—pancreatic cancer	0.00034	0.00179	CcSEcCtD
Clobetasol propionate—Rash—Gemcitabine—pancreatic cancer	0.000336	0.00177	CcSEcCtD
Clobetasol propionate—Dermatitis—Gemcitabine—pancreatic cancer	0.000336	0.00177	CcSEcCtD
Clobetasol propionate—Headache—Gemcitabine—pancreatic cancer	0.000334	0.00176	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000331	0.00174	CcSEcCtD
Clobetasol propionate—Rash—Fluorouracil—pancreatic cancer	0.000331	0.00174	CcSEcCtD
Clobetasol propionate—Dermatitis—Fluorouracil—pancreatic cancer	0.00033	0.00174	CcSEcCtD
Clobetasol propionate—Headache—Fluorouracil—pancreatic cancer	0.000328	0.00173	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000327	0.00172	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000327	0.00172	CcSEcCtD
Clobetasol propionate—Pain—Docetaxel—pancreatic cancer	0.000324	0.0017	CcSEcCtD
Clobetasol propionate—Alopecia—Epirubicin—pancreatic cancer	0.000317	0.00167	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—pancreatic cancer	0.000313	0.00164	CcSEcCtD
Clobetasol propionate—Alopecia—Doxorubicin—pancreatic cancer	0.000294	0.00154	CcSEcCtD
Clobetasol propionate—Erythema—Doxorubicin—pancreatic cancer	0.000289	0.00152	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000279	0.00147	CcSEcCtD
Clobetasol propionate—Pruritus—Docetaxel—pancreatic cancer	0.000268	0.00141	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000264	0.00139	CcSEcCtD
Clobetasol propionate—Infection—Epirubicin—pancreatic cancer	0.000254	0.00133	CcSEcCtD
Clobetasol propionate—Skin disorder—Epirubicin—pancreatic cancer	0.000248	0.0013	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Clobetasol propionate—Rash—Docetaxel—pancreatic cancer	0.000239	0.00125	CcSEcCtD
Clobetasol propionate—Dermatitis—Docetaxel—pancreatic cancer	0.000238	0.00125	CcSEcCtD
Clobetasol propionate—Headache—Docetaxel—pancreatic cancer	0.000237	0.00125	CcSEcCtD
Clobetasol propionate—Infection—Doxorubicin—pancreatic cancer	0.000235	0.00123	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—pancreatic cancer	0.000229	0.00121	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—pancreatic cancer	0.000229	0.00121	CcSEcCtD
Clobetasol propionate—Pain—Epirubicin—pancreatic cancer	0.000218	0.00115	CcSEcCtD
Clobetasol propionate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000212	0.00112	CcSEcCtD
Clobetasol propionate—Pain—Doxorubicin—pancreatic cancer	0.000202	0.00106	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000188	0.000989	CcSEcCtD
Clobetasol propionate—Pruritus—Epirubicin—pancreatic cancer	0.000181	0.00095	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000174	0.000915	CcSEcCtD
Clobetasol propionate—Pruritus—Doxorubicin—pancreatic cancer	0.000167	0.000879	CcSEcCtD
Clobetasol propionate—Rash—Epirubicin—pancreatic cancer	0.000161	0.000846	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—pancreatic cancer	0.000161	0.000845	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—pancreatic cancer	0.00016	0.000841	CcSEcCtD
Clobetasol propionate—Rash—Doxorubicin—pancreatic cancer	0.000149	0.000783	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—pancreatic cancer	0.000149	0.000782	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—pancreatic cancer	0.000148	0.000778	CcSEcCtD
